// App-Quantinova.ai

8552 : Long-term results of a phase I/II trial of nelfinavir with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.

Researchers

Presenter

  • Ramesh Rengan

Principal Investigators

  • Rosemarie Mick

  • Daniel Pryma

  • Lilie L. Lin

  • John Paul Christodouleas

  • John Peter Plastaras

  • Charles B. Simone

  • Anjali K. Gupta

  • Tracey L. Evans

  • James Stevenson

  • Corey J. Langer

  • John Kucharczuk

  • Joseph S. Friedberg

  • Sarah Lam

  • Dana Patsch

  • Stephen M. Hahn

  • Amit Maity

Medical Centers

  • Department of Radiology, University of Washington, Seattle, WA

  • University of Pennsylvania, Philadelphia, PA

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • Hospital of the University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania, Philadelphia, PA

  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

  • Cleveland Clinic, Cleveland, OH

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

  • University of Maryland School of Medicine, Baltimore, MD

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

  • Nelfinavir mesylate

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00589056

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved